title: Pain management in blind, painful eyes: clinical experience with retrobulbar alcohol injection in 4 cases.
abstract: Ocular pain is often difficult to treat and may be caused by many eye diseases. The first step in pain management is medical therapy combined with analgesics; however, severe and resistant cases may require neurolytic eye blocks or definitive surgery. Retrobulbar block with neurolytic agents such as alcohol may be preferred, if the eye is cosmetically normal or the patient is medically or psychologically unsuitable for enucleation or evisceration. Here, we present our successful and efficient pain management using retrobulbar alcohol injection in 4 patients with painful blind eyes. Patients with neovascular glaucoma presenting with painful blind eyes were accepted to our clinic for pain management. The patients had continuous pain with an increasing severity in the recent months. We planned to perform retrobulbar alcohol injection as the pain of the patients was resistant to medical therapy. We noted measurement of verbal analogue scale for pain (VAS) before the block (7, 9, 9 and 10, respectively), after retrobulbar lidocaine and alcohol injection, at the postoperative 1st day, 1st, 2nd 3rd and 4th weeks, and 3rd, 4th, 5th, 6th and 12th months. Early and late complications were also recorded. On the first day after injection, no patient required additive analgesic therapy and their VAS scores were 0, 0, 0, and 3, respectively. Except for one patient who underwent enucleation because of a bacterial infection, the other three patients' VAS scores were 1, 0 and 1 at the 12th month assessment. We suggest that neurolytic retrobulbar block is an efficient pain management strategy in blind painful eyes.
authors.affiliation: Department of Anaesthesiology and Reanimation, Başkent University, Ankara, Turkey. oyacok@yahoo.com
authors.forename: Oya Yalçin
authors.initials: OY
authors.lastname: Çok
authors.forename: Hatice Evren
authors.initials: HE
authors.lastname: Eker
authors.forename: Silay
authors.initials: S
authors.lastname: Cantürk
authors.forename: Rana
authors.initials: R
authors.lastname: Yaycioğlu
authors.forename: Aniş
authors.initials: A
authors.lastname: Ariboğan
authors.forename: Gülnaz
authors.initials: G
authors.lastname: Arslan
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000779:Anesthetics, Local / Q000008:administration & dosage; D001766:Blindness / Q000150:complications*; D000431:Ethanol / Q000008:administration & dosage*; D058447:Eye Pain / Q000209:etiology / Q000628:therapy*; D005260:Female; D015355:Glaucoma, Neovascular / Q000150:complications*; D006801:Humans; D056965:Injections, Intraocular; D008012:Lidocaine / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009407:Nerve Block / Q000379:methods*; D009900:Optic Nerve; D010147:Pain Measurement; D010148:Intractable Pain / Q000209:etiology / Q000628:therapy*
chemical_list: D000779:Anesthetics, Local; D000431:Ethanol; D008012:Lidocaine